Juan G. Abraldes spends much of his time researching Internal medicine, Cirrhosis, Gastroenterology, Portal hypertension and Surgery. His Internal medicine study frequently involves adjacent topics like Endocrinology. Juan G. Abraldes mostly deals with Portal venous pressure in his studies of Cirrhosis.
His study in the fields of Chronic liver disease and Prednisolone under the domain of Gastroenterology overlaps with other disciplines such as Risk assessment and Standard treatment. His Portal hypertension study integrates concerns from other disciplines, such as Mean arterial pressure, Varices, Cardiology, Portal vein thrombosis and Vascular disease. His Surgery research is multidisciplinary, incorporating perspectives in Clinical trial and Transjugular intrahepatic portosystemic shunt.
Juan G. Abraldes mainly investigates Internal medicine, Cirrhosis, Gastroenterology, Portal hypertension and Portal venous pressure. His studies deal with areas such as Endocrinology and Cardiology as well as Internal medicine. The various areas that he examines in his Cirrhosis study include Decompensation and Surgery.
Juan G. Abraldes focuses mostly in the field of Gastroenterology, narrowing it down to topics relating to Randomized controlled trial and, in certain cases, Model for End-Stage Liver Disease. The Portal hypertension study combines topics in areas such as Hemodynamics, Vascular resistance, Radiology and Propranolol. Juan G. Abraldes has included themes like Mean arterial pressure, Anesthesia, Liver function, Transient elastography and Blood pressure in his Portal venous pressure study.
His main research concerns Internal medicine, Cirrhosis, Gastroenterology, Liver disease and Portal hypertension. In general Cirrhosis, his work in Transjugular intrahepatic portosystemic shunt is often linked to In patient linking many areas of study. His Gastroenterology study combines topics from a wide range of disciplines, such as Liver transplantation, Nonalcoholic fatty liver disease, Beta, Simvastatin and Cohort.
His Liver disease research includes elements of Fibrosis, Esophageal varices, Gut flora and Alcoholic hepatitis. Juan G. Abraldes is involved in the study of Portal hypertension that focuses on Portal venous pressure in particular. The study incorporates disciplines such as Liver function and Cardiology in addition to Portal venous pressure.
His scientific interests lie mostly in Internal medicine, Cirrhosis, Gastroenterology, Liver disease and Portal hypertension. In his works, he performs multidisciplinary study on Internal medicine and Risk assessment. His Cirrhosis research is multidisciplinary, relying on both Decompensation, Severity of illness, Surgery and Adverse effect.
His studies deal with areas such as Odds ratio, Simvastatin and Creatine kinase as well as Gastroenterology. His research in Portal hypertension is mostly concerned with Portal venous pressure. His Portal venous pressure research includes themes of Hepatorenal syndrome and Liver function.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.
Guadalupe Garcia‐Tsao;Juan G. Abraldes;Annalisa Berzigotti;Jaime Bosch;Jaime Bosch.
Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
Juan Carlos García-Pagán;Karel Caca;Christophe Bureau;Wim Laleman.
The New England Journal of Medicine (2010)
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Juan G. Abraldes;Ilaria Tarantino;Juan Turnes;Juan Carlos Garcia-Pagan.
The clinical use of HVPG measurements in chronic liver disease
Jaime Bosch;Juan G. Abraldes;Annalisa Berzigotti;Juan Carlos García-Pagan.
Nature Reviews Gastroenterology & Hepatology (2009)
Improved Clinical Outcome Using Polytetrafluoroethylene-Coated Stents for TIPS: Results of a Randomized Study
Christophe Bureau;Juan carlos Garcia-Pagan;Philippe Otal;Gilles Pomier-Layrargues.
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
Annalisa Berzigotti;Susana Seijo;Umberto Arena;Juan G. Abraldes.
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.
Jaime Bosch;Dominique Thabut;Flemming Bendtsen;Gennaro D’Amico.
The management of portal hypertension: rational basis, available treatments and future options.
Jaime Bosch;Annalisa Berzigotti;Juan Carlos Garcia-Pagan;Juan G. Abraldes.
Journal of Hepatology (2008)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G Abraldes;Agustin Albillos;Rafael Bañares;Juan Turnes.
Current management of portal hypertension.
Jaime Bosch;Juan G Abraldes;Roberto Groszmann.
Journal of Hepatology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: